This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 May;134(5):1456-1459.

doi: 10.1038/jid.2013.496. Epub 2013 Nov 22.

Deregulated type I IFN response in TREX1-associated familial chilblain lupus

Affiliations

Affiliations

¹ Institute for Immunology, Technical University Dresden, Dresden, Germany.
² Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany.
³ Department of Pediatrics, University Hospital, Technical University Dresden, Dresden, Germany.
⁴ Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany. Electronic address: Claudia.guenther@uniklinikum-dresden.de.

PMID: 24270665
DOI: 10.1038/jid.2013.496

Free article

Deregulated type I IFN response in TREX1-associated familial chilblain lupus

Katrin Peschke et al. J Invest Dermatol. 2014 May.

Free article

. 2014 May;134(5):1456-1459.

doi: 10.1038/jid.2013.496. Epub 2013 Nov 22.

Affiliations

¹ Institute for Immunology, Technical University Dresden, Dresden, Germany.
² Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany.
³ Department of Pediatrics, University Hospital, Technical University Dresden, Dresden, Germany.
⁴ Department of Dermatology, University Hospital, Technical University Dresden, Dresden, Germany. Electronic address: Claudia.guenther@uniklinikum-dresden.de.

PMID: 24270665
DOI: 10.1038/jid.2013.496

Erratum in

J Invest Dermatol. 2014 May;134(5). doi: 10.1038/jid.2014.136
J Invest Dermatol. 2014 Sep;134(9):2475

No abstract available

PubMed Disclaimer

Similar articles

Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
Fye JM, Orebaugh CD, Coffin SR, Hollis T, Perrino FW. Fye JM, et al. J Biol Chem. 2011 Sep 16;286(37):32373-82. doi: 10.1074/jbc.M111.276287. Epub 2011 Aug 1. J Biol Chem. 2011. PMID: 21808053 Free PMC article.
Systemic involvement in TREX1-associated familial chilblain lupus.
Günther C, Hillebrand M, Brunk J, Lee-Kirsch MA. Günther C, et al. J Am Acad Dermatol. 2013 Oct;69(4):e179-81. doi: 10.1016/j.jaad.2013.04.020. J Am Acad Dermatol. 2013. PMID: 24034389 No abstract available.
Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
Tüngler V, Silver RM, Walkenhorst H, Günther C, Lee-Kirsch MA. Tüngler V, et al. Br J Dermatol. 2012 Jul;167(1):212-4. doi: 10.1111/j.1365-2133.2012.10813.x. Br J Dermatol. 2012. PMID: 22356656 No abstract available.
Human disease phenotypes associated with mutations in TREX1.
Rice GI, Rodero MP, Crow YJ. Rice GI, et al. J Clin Immunol. 2015 Apr;35(3):235-43. doi: 10.1007/s10875-015-0147-3. Epub 2015 Mar 4. J Clin Immunol. 2015. PMID: 25731743 Review.
Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?
Fiehn C. Fiehn C. Curr Rheumatol Rep. 2017 Aug 26;19(10):61. doi: 10.1007/s11926-017-0689-x. Curr Rheumatol Rep. 2017. PMID: 28844088 Review.

See all similar articles

Cited by

Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response.
Du H, Xiao N, Zhang S, Zhou X, Zhang Y, Lu Z, Fu Y, Huang M, Xu S, Chen Q. Du H, et al. iScience. 2023 Jun 10;26(7):107090. doi: 10.1016/j.isci.2023.107090. eCollection 2023 Jul 21. iScience. 2023. PMID: 37416470 Free PMC article.
Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus.
Miyagawa F. Miyagawa F. J Clin Med. 2023 Jan 27;12(3):987. doi: 10.3390/jcm12030987. J Clin Med. 2023. PMID: 36769633 Free PMC article. Review.
Clinical aspects of cutaneous lupus erythematosus.
Elmgren J, Nyberg F. Elmgren J, et al. Front Med (Lausanne). 2023 Jan 9;9:984229. doi: 10.3389/fmed.2022.984229. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698816 Free PMC article. Review.
Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus.
Fetter T, Braegelmann C, de Vos L, Wenzel J. Fetter T, et al. Front Med (Lausanne). 2022 May 30;9:915828. doi: 10.3389/fmed.2022.915828. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35712102 Free PMC article. Review.
The skin as a critical window in unveiling the pathophysiologic principles of COVID-19.
Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. Magro C, et al. Clin Dermatol. 2021 Nov-Dec;39(6):934-965. doi: 10.1016/j.clindermatol.2021.07.001. Epub 2021 Jul 22. Clin Dermatol. 2021. PMID: 34920833 Free PMC article. Review.

See all "Cited by" articles

References

1. J Biol Chem. 2001 May 18;276(20):17022-9 - PubMed
1. Immunity. 2012 Jan 27;36(1):120-31 - PubMed
1. Clin Exp Immunol. 2014 Jan;175(1):17-24 - PubMed
1. Am J Hum Genet. 2006 Oct;79(4):731-7 - PubMed
1. Am J Med Genet A. 2011 Jan;155A(1):235-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations
- scite Smart Citations
Medical
- Genetic Alliance
Molecular Biology Databases
- Mouse Genome Informatics (MGI)